Times are shown in your local time zone GMT
Ad-blocker Detected - Your browser has an ad-blocker enabled, please disable it to ensure your attendance is not impacted, such as CPD tracking (if relevant). For technical help, contact Support.
Dr Alicia Chan
University of Adelaide
Professional Bio
MBBS FRACP PhD FCSANZ
Dr Alicia Chan is a clinical and academic Cardiologist who specialises in heart failure and implantable devices therapy from South Australia
Dr Alicia Chan graduated from the University of Adelaide and completed her cardiology training in Adelaide. She undertook further training at The New Royal Infirmary of Edinburgh, Scotland and a postdoctoral fellowship in implantable devices therapy at the University of Calgary, Canada.
Her interests include heart disease in women, having completed her PhD (Dean’s list 2013) entitled “Cardiovascular Risk Assessment in Women: Impact of Ageing, Polycystic Ovarian Syndrome and Menopause on Nitric Oxide Signalling” and also heart failure mechanisms and therapeutics, with international presentations and publications in these fields. Her latest contribution was in the “Consensus Statement on the current prevention and management of Heart Failure” MJA 2022.
She is the current SA Board Representative Cardiac Society ANZ, Chair of Cardiology Females in SA (CAFE-SA, CSANZ), SA Advisory Board member of National Heart Foundation and continues to be active in teaching through the University of Adelaide.
Dr Alicia Chan is a clinical and academic Cardiologist who specialises in heart failure and implantable devices therapy from South Australia
Dr Alicia Chan graduated from the University of Adelaide and completed her cardiology training in Adelaide. She undertook further training at The New Royal Infirmary of Edinburgh, Scotland and a postdoctoral fellowship in implantable devices therapy at the University of Calgary, Canada.
Her interests include heart disease in women, having completed her PhD (Dean’s list 2013) entitled “Cardiovascular Risk Assessment in Women: Impact of Ageing, Polycystic Ovarian Syndrome and Menopause on Nitric Oxide Signalling” and also heart failure mechanisms and therapeutics, with international presentations and publications in these fields. Her latest contribution was in the “Consensus Statement on the current prevention and management of Heart Failure” MJA 2022.
She is the current SA Board Representative Cardiac Society ANZ, Chair of Cardiology Females in SA (CAFE-SA, CSANZ), SA Advisory Board member of National Heart Foundation and continues to be active in teaching through the University of Adelaide.